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ABSTRACT 
The etiology of Riedel’s invasive fibrous thyroiditis (IFT) has re- 
mained obscure. This rare disorder has been confused in the past with 
the more common fibrous variant of Hashimoto’s disease. The typical 
histological features of IFT, in particular the presence of an invasive 
fibrosclerotic process in conjunction with a prominent chronic inflam- 
matory infiltrate, suggest that the release of fibrogenic cytokines and 
other factors from these cellular infiltrates may play an important role 
in the pathogenesis of this condition. Our observations in routinely pro- 
cessed tissue sections obtained from patients with documented IFT of 
striking tissue eosinopbilia led us to hypothesize that eosinophils and 
their products may play a role in the evolution of this disease. Immu- 
nofluorescence staining with affinity-purified polyclonal rabbit antibody 
directed against human eosinophil granule major basic protein revealed 
marked tissue eosinophilia and abundant extracellular deposition of 
major basic protein in all specimens from 16 patients with IFT. By 
contrast, only occasional eosinophils and no extracellular major basic 
protein were detected in control thyroid tissues obtained from patients 
with multinodular goiter, Graves’ disease, Hashimoto’s disease, and 
normal thyroid tissue. The presence of marked eosinophil infiltration 
and extracellular major basic protein deposition in IFT and other asso- 
ciated fibrosclerotic conditions suggests a role for eosinophils and their 
products in propagating the fibrogenesis seen in WI’. (J Clin Endocrinol 
Metab 81: 977-984, 1996) 
S INCE its recognition in 1896 (1) and its histopathological description (2), invasive fibrous thyroiditis (IFT; 
Riedel’s struma), the rarest type of thyroiditis, has remained 
a mysterious entity of unknown etiology. Clinically, IFT is 
characterized by the gradual emergence of a firm solid an- 
terior neck mass. Histological examination shows a chronic 
inflammatory fibrous process frequently arising in conjunc- 
tion with a preexisting goiter. The invasive fibrosclerotic 
process typically continues well beyond the thyroid capsule, 
progressively invading and destroying the thyroid gland and 
neighboring neck tissues (3-5). Histological features charac- 
teristic of IFT include a dense, partially inflammatory fibro- 
sclerotic process that may replace the entire thyroid gland. 
This process typically infiltrates and encompasses surround- 
ing neck structures, such as muscles, blood vessels, nerves, 
and trachea (2, 5). The inflammatory infiltrate is a mixed 
population of mononuclear cells, consisting predominantly 
of activated T lymphocytes, macrophages, and aggregates of 
B lymphocytes (2, 5-8). Frequently, IFT is associated with 
manifestations of extracervical fibrosis, which may occur in 
locations such as the orbit, the mediastinum, the biliary tract, 
and the retroperitoneum (3, 4). 
roids, and the presence of a mononuclear cell infiltrate within 
the fibrosclerotic process suggest an active immune- 
mediated process in the pathogenesis of IFT. Paracrine and 
autocrine factors, released locally by infiltrating lympho- 
cytes/macrophages and residential cells, may act as stimu- 
lators of the fibrogenic process (10, 11). However, a variety 
of products derived from other immunocompetent cells, 
such as mast cells and eosinophils, may also act as potent 
stimulators of fibrogenesis (12-15). 
The detection of thyroid-specific autoantibodies in many 
patients with IFT (3, 6, 9), the response of IFT to corticoste- 
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In the process of reviewing our institution’s histological ex- 
perience in 33 patients with IFI’ over the past 60 yr, we observed 
a striking degree of tissue eosinophilia in the majority of he- 
matoxylin- and eosin-stained slides examined. Certain eosino- 
phi1 products exert cytotoxic effects on mammalian cells and are 
known to activate basophils, platelets, and mast cells as well as 
to stimulate fibrogenic cellular functions (12-19). Major basic 
protein (MBP), one of several eosinophil products, has been 
localized to the eosinophil granule core (12,20). The detection 
of its presence and release, both in vitro and in viva, has been 
used as a marker of eosinophil infiltration and degranulation 
(20-22). Using an indirect immunofluorescence technique for 
localization of eosinophil granule MBP, we tested the hypoth- 
esis that tissue eosinophilia and eosinophil degranulation are 
present in biopsy specimens from patients with IFT. Our results 
indicate that eosinophil infiltration and degranulation are fre- 
quent and prominent features of the inflammatory fibrosis in 
IET. 
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Patients 
Subjects and Methods 
*This work was supported in part by grants to A.E.H. from Deutsche Surgical biopsy specimens from 16 patients with histologically doc- 
Forschungsgemeinschaft (Bonn, Germany; He 1485/2-l and He 1485/ umented Riedel’s invasive fibrous thyroiditis, diagnosed at the Mayo 
3-l) and grants from the NIH (AI-15231 and AI-09728). Clinic between 1932 and 1990, were evaluated. These tissue samples 
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originated from 10 women and 6 men with a mean age of 51 yr and a 
mean duration of disease of 2.8 yr at the time of diagnosis. Control 
tissues included biopsy specimens of thyroid tissue obtained from nor- 
mal individuals (n = 5; autopsy specimens), patients with multinodular 
goiter (n = 4), Graves’ disease (n = 4), and Hashimoto’s thyroiditis 
(n = 5). All specimens had been fixed in 10% buffered formalin (pH 7.0) 
and embedded in paraffin for sectioning and histological studies. 
Detection of MBP by immunofluorescence staining 
Indirect immunofluorescence for the detection of eosinophil granule 
MBP in formalin-fixed paraffin-embedded sections was performed as 
described previously (21). In brief, three 6-pm serial sections were cut 
from each paraffin block and affixed to glass slides by LePage’s Bond 
Fast resin glue (LePage’s Ltd., Bramalea, Canada). The first and third 
sections were used for immunofluorescence, and the second section was 
stained with hematoxylin-eosin. For the immunofluorescence proce- 
dure, two sections from each block were deparaffinized in xylene and 
rehvdrated in absolute alcohol, 80% ethanol, and distilled water. The 
seckons were incubated for 1 h at 37 C in a 0.1% trypsin solution to 
unmask antigenic sites, then incubated overnight in 10% normal goat 
serum to block nonspecific binding by fluorescein-labeled second an- 
tibody, goat antirabbit IgG. The slides were washed and overlaid with 
equal concentrations of either normal rabbit IgG (NRIgG) or affinity- 
purified rabbit anti-MBP. After incubation at 37 C for 30 min, the sections 
were washed and incubated for 30 min in 1% chromotrope 2R to block 
nonspecific binding of fluorescein dye to the eosinophils. After another 
wash, the sections were overlaid with affinity-purified fluoresceinated 
goat antirabbit IgG and incubated at 37 C for 30 min. After a final wash, 
the slides were mounted with glycerol containing paraphenylenedia- 
mine to delay the fading of fluorescence, coverslipped, and sealed with 
clear nail polish. 
The slides were examined with a Zeiss (Carl Zeiss, Inc., Oberkochen, 
Germany) standard microscope equipped with standard light illumi- 
nation, Zeiss IV FL vertical illumination for epifluorescence, and a flu- 
orescein filter system. Areas showing positive immunofluorescence 
indicative of eosinophil infiltration and degranulation were photo- 
graphed, and the corresponding areas on consecutive hematoxylin- and 
eosin-stained sections were documented for reference. 
The specificity of anti-MBP staining in formalin-fixed paraffin- 
embedded tissue has been investigated in detail and reported previously 
(20-23). Briefly, immunoabsorption of anti-MBP serum with MBP re- 
moved reactivity, whereas immunoabsorption with unrelated basic pro- 
teins failed to remove reactivity. To further reduce the possibility of 
nonspecific staining of other tissue elements, we used affinitv chroma- 
tography-purified yeagents. In the first stage of the assay, an affinity 
chromatography-purified rabbit antihuman MBP was used to localize 
MBP, and a staphylococcal protein A-purified NRIgG was used as the 
negative control. The preparation of these reagents-has been described 
in detail previously (20). Equal concentrations of NRIgG and the affinity- 
purified anti-MBP were used in the immunofluorescence procedure. The 
affinity-purified anti-MBP does not react with normal tissues, including 
lung (22), skin (22), lymph node (24), kidney (25), liver (26), and orbital 
tissue (27). In addition, we used an affinity-purified fluorescein- 
conjugated goat antirabbit IgG (Southern Biotechnology Associates, 
Birmingham, AL) as the second stage antibody. 
Immunohistochemistry 
Immunohistochemical staining of tissue sections was performed us- 
ing monoclonal antibodies directed against thyroglobulin, CD2 (lym- 
phocytes), CD3 (T cells), CD26 (B cells), and CD45RO (memory T cells/ 
macrophages; all obtained from Dakopatts Corp., Santa Barbara, CA) in 
a highly sensitive three-stage immunoperoxidase protocol, as described 
previously (27-29). Parallel sections with the primary antibody replaced 
by unrelated antibodies, nonimmune mouse IgG of the same isotype, 
and with omission of each layer in turn were examined to further assure 
specificity and exclude cross-reactivities between the antibodies and 
conjugates employed. 
Evaluation of immunofluorescent staining 
Tissue eosinophilia, as demonstrated by immunofluorescent staining 
of intracellular MBP, and eosinophil degranulation, as demonstrated by 
extracellular MBP deposition, were evaluated in a blinded protocol by 
two independent observers. The degree of eosinophil infiltration char- 
acteristic of the entire specimen was subjectively scored on a scale from 
0 to 3+ at X 160 magnification. If no or only a rare eosinophil was present, 
a score of 0 was assigned; if tissue sections contained a few eosinophils, 
a score of 1+ was assigned. A tissue section containing moderate num- 
bers of eosinophils was scored 2+, and a section containing numerous 
and confluent eosinophils was scored 3+. The degree of extracellular 
MBP deposition was scored similarly. If no extracellular MBP staining 
was present, a score of 0 was assigned, minimal extracellular MBP 
deposition was scored 1+, moderate quantities (involving between lo- 
33% of the tissue) were scored 2+, whereas 3+ was assigned to spec- 
imens exhibiting marked deposition of MBP (>33% of the tissue 
involved). 
Statistical analysis 
Statistical analysis was performed using ,$ analysis. P < 0.05 was 
considered a statistically significant difference. 
Results 
Tissue specimens obtained from the anterior neck mass of 
all 16 patients with IFT revealed the typical histological fea- 
tures of an invasive fibrosclerotic process that extended be- 
yond the thyroid capsule and infiltrated into the surrounding 
neck musculature (Fig. 1A). In addition, in all specimens 
examined, marked infiltration into the fibrous connective 
tissue and the adjacent strap muscles by mononuclear cells 
was present (Fig. 1B). In 11 of 16 specimens, thyroid tissue 
was largely replaced by collagen fibers and dense connective 
tissue (Fig. 1C). In fact, in 12 of 16 specimens, immunostain- 
ing for thyroglobulin revealed the presence of only small 
remnants of residual thyroid tissue (Fig. 1D). 
Immunofluorescent localization of MBP could be catego- 
rized as one of four obvious patterns: 1) infiltration by intact 
eosinophils into connective tissue in the virtual absence of 
extracellular deposition of MBP (Fig. 2, A and B), 2) coex- 
istence of tissue infiltration by intact eosinophils as well as 
extracellular MBP deposition (Fig. 2, C and D), 3) a punctate 
pattern of extracellular MBP deposition in proximity to dense 
collagen bundles and within dense fibrous tissue in the vir- 
tual absence of intact eosinophils (Fig. 2E), and 4) absence of 
intact eosinophils and presence of a diffuse staining pattern 
of extracellular MBP deposition within dense connective tis- 
sue and adjacent neck musculature, reflecting massive eosi- 
nophil degranulation (Fig. 2F). 
Eosinophil infiltration and extracellular MBP deposition 
were observed in 15 of 16 patients with histologically 
proven Riedel’s invasive fibrous thyroiditis. Infiltration of 
tissue specimens by intact eosinophils was graded +3 in 
5, +2 in 8, +l in 2, and 0 in one instance. Extracellular MBP 
deposition was graded +3 in 3, +2 in 7, +l in 5, and 0 in 
one instance. By contrast, no extracellular deposition of 
MBP was detected in any of the control tissues (0 of 18) 
derived from 4 patients with Graves’ disease, 5 patients 
with Hashimoto’s thyroiditis, 4 patients with euthyroid 
multinodular goiter, and five normal individuals (each P 
< 0.0001 compared to IFT specimens). A few scattered 
eosinophils, present in most thyroid tissue samples (multi- 
nodular goiter, Graves’, and Hashimoto’s specimens) were 
similarly detected in normal thyroid tissue. Only one 
Graves’ specimen and two Hashimoto’s specimens re- 
vealed eosinophil numbers slightly greater than those in 
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FIG. 1. Histological sections of thyroid tissue derived from a patient with IFT. Note the invasive nature of the fibrosclerotic process that extends 
beyond the thyroid capsule and infiltrates into the adjacent neck musculature (A; hematoxylin and eosin stain; original magnification, X80). 
A higher power view demonstrates marked infiltration of the neck musculature by lymphocytes, macrophages, and eosinophils (B; hematoxylin 
and eosin stain; original magnification, x 160). C, An isolated thyroid follicle encased by collagen fibers and dense connective tissue infiltrated 
by mononuclear cells (hematoxylin and eosin stain; original magnification, X240). Immunostaining for thyroglobulin demonstrates a small 
number of remnant thyroid follicles and the replacement of thyroid tissue by the dense fibrosclerotic process (D; original magnification, X 160). 
normal thyroid tissues. However, quantitation of eosino- 
phi1 numbers in these specimens produced a score of 0 
(P < 0.0001 compared to IFT). 
In all but one IFT specimen, infiltration by intact eosi- 
nophils was generally most prominent in areas of loose con- 
nective tissue and was found throughout the fibrous process 
(Fig. 3A). Dense fibrous tissue surrounding mononuclear cell 
aggregates showed both intact eosinophils and punctate ex- 
tracellular MBP deposits (Fig. 3B). In addition, in both the 
perivascular spaces of numerous blood vessels and within 
mononuclear cell aggregates, intense staining for intact eosi- 
nophils as well as extracellular MBP were noted (Fig. 4, A-D). 
Further, in all but one IFT specimen, large numbers of intact 
eosinophils were detected in areas where the fibrous process 
was diffusely infiltrated by CD3+/CD45RO+-activated lym- 
phocytes and macrophages. In apparent contrast to this pat- 
tern, intact eosinophils and MBP deposits were not detected 
in the central portion of aggregates populated predomi- 
nantly by B lymphocytes (data not shown). Further, marked 
tissue eosinophilia and MBP deposition were present in areas 
where the fibrous process invaded adjacent structures, 
namely the striated neck musculature (Fig. 5, A and B). In 
these areas, diffuse extracellular MBP deposition was fre- 
quently observed, reflecting profound eosinophil degranu- 
lation and extensive MBP release into the surrounding tissue 
(Fig. 6A). In contrast to the pronounced tissue eosinophilia 
and MBP deposition in areas affected by the fibrogenic pro- 
cess, the remaining thyroid tissue in all IFT specimens was 
virtually devoid of both intact eosinophils and extracellular 
MBP deposits (Fig. 6B). 
Discussion 
Tissue eosinophilia and eosinophil degranulation occur in 
various syndromes associated with fibrosis, such as the toxic 
oil syndrome, the eosinophilia myalgia syndrome, the hy- 
pereosinophilic syndrome, eosinophilic endomyocardial dis- 
ease, and the nodular sclerosing variant of. Hodgkin’s disease 
(24,30,31). In addition, infiltration with eosinophils has been 
associated with a variety of immune-mediated conditions, 
including urticaria (20), allograft rejection (25,261, and orbital 
pseudotumor (27). Recently, tissue eosinophilia and eosino- 
phi1 degranulation were reported in the majority of patients 
with inflammatory fibrosing conditions, including retroper- 
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FIG. 2. Representative examples of the various patterns of tissue eosinophilia and extracellular MBP deposition observed in serial sections 
stained with hematoxylin and eosin (A and C) or rabbit antihuman MBP antibody (B, D, E, and F). A and B, Tissue infiltration by intact 
eosinophils; C and D, coexistence of pronounced tissue infiltration by intact eosinophils and faint extracellular MBP deposition; E, punctate 
pattern of extracellular MBP deposition; F, marked degree of eosinophil degranulation as demonstrated by a diffuse staining pattern of 
extracellular MBP deposition. The scores for eosinophil infiltration were +3 (B), +2 (D and E), and + 1 (F), and the scores for extracellular MBP 
deposition were +l (B), +2 (D), and +3 (E and F; original magnifications, x160; magnification for F, X240). 
itoneal fibrosis, sclerosing cholangitis, sclerosing mediasti- sociated with IFT. Previously, this condition has not been 
nitis, and pulmonary fibrosis (18). associated with marked eosinophil infiltration as a promi- 
In this study, we tested the hypothesis that eosinophil nent feature. We found marked infiltration by eosinophils 
infiltration and eosinophil degranulation, as demonstrated and extracellular deposition of MBP within the fibrosclerotic 
by the intra- and extracellular localization of MBP, are as- process in IFT. The magnitude of eosinophil infiltration cor- 
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FIG. 3. Representative examples of tissue eosinophilia and extracellular MBP deposition observed in serial sections stained with rabbit 
antihuman MBP protein antibody. A, Infiltration of loose connective tissue by predominantly intact eosinophils. B, Strands of dense connective 
tissue surrounding B cell-rich lymphoid follicles and remnant thyroid follicles reveal the presence of both intact eosinophils and extracellular 
MBP deposits (original magnifications, x 160). The scores for eosinophil infiltration were +2 (A and B), and the scores for extracellular MBP 
deposition were zero (A) and +2 (B; original magnifications, X 160). 
FIG. 4. Eosinophil infiltration of fibrous tissue in a biopsy specimen taken from the lateral portion of the thyroid gland in a patient with IFT. 
A and C, Section stained with rabbit antihuman MBP antibody; B and D, serial section stained with normal rabbit IgG (original magnifications, 
X80 and X 160, respectively). Marked infiltration by intact eosinophils (brilliantly fluorescent ovals) and extracellular MBP deposition is 
concentrated in the perivascular area and the adjacent connective tissue, whereas more distant areas are spared. The score for eosinophil 
infiltration was +l, and the score for extracellular MBP deposition was +3. 
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FIG. 5. Infiltration by eosinophils and deposition of MBP in a biopsy specimen taken from the lateral portion of the anterior neck mass of a 
patient with IFT. A, Section stained with rabbit antihuman MBP; B, serial section stained with hematoxylin-eosin. Both intact eosinophils and 
small extracellular MBP deposits are present in areas showing mononuclear cell infiltration and disruption of skeletal muscle (original 
magnifications, X200). 
FIG. 6. A, Marked deposition of extracellular MBP in a biopsy specimen taken from the lateral portion of the anterior neck mass of a patient 
with IFT. Note the stringy staining pattern of extracellular MBP deposition surrounding degenerating skeletal muscle fibers. B, Normal 
appearing thyroid tissue located in an area not affected by invasive flbrosclerosis in a patient with IFT. Note the presence of only occasional 
eosinophils and the absence of extracellular MBP deposits (original magnifications, x200). 
related best with the presence and extent of inflammatory 
infiltrates rich in activated T lymphocytes/macrophages and 
was most marked in perivascular zones and areas with abun- 
dant immature connective tissue. Of note, the single patient 
with IFT and no evidence of tissue eosinophilia or eosinophil 
degranulation presented clinically with a 4-yr history of a 
thyroid mass, and histology revealed extensive fibrosis with 
only minor infiltration by inflammatory cells, suggesting 
long standing inactive disease. 
The distribution of extracellular MBP deposits commonly 
paralleled that of intact eosinophils. However, these deposits 
were also found independent of intact eosinophils, particu- 
larly in dense connective tissue and areas of fibrous invasion 
into thyroid and striated muscle tissues. These results to- 
gether with prior observations (18) suggest that eosinophils 
migrate into immature connective tissues, presumably in 
response to chemotactic stimuli (32), degranulate, and re- 
lease their cationic toxins into the connective tissue. Al- 
though MBP was localized in this study, various other eosi- 
nophil products are probably also released, including the 
eosinophil cationic protein, eosinophil peroxidase, and eosi- 
nophil-derived neurotoxin (12, 13, 18, 33-35). 
Several recent reports suggest a potential role for eosi- 
nophils and MBP in tissue fibrogenesis. Eosinophil extracts 
are capable of stimulating fibroblast proliferation, and eosi- 
nophil-conditioned medium has been shown to be mitogenic 
for fibroblasts, suggesting that an eosinophil product may 
directly cause fibrosis (17). In addition, eosinophil-derived 
neurotoxin appears to be capable of stimulating fibroblast 
proliferation (36). Furthermore, eosinophils have been 
shown to stimulate the replication of fibroblasts in vitro (19). 
Recently, eosinophils have been found to release certain cy- 
tokines (37, 38) and to express genes for various cytokines, 
including transforming growth factor-p, a potent stimulator 
of fibroblast chemotaxis, proliferation, and synthetic capac- 
ities (39). These observations in conjunction with our present 
data suggest that tissue eosinophilia and eosinophil degran- 
ulation may represent an important fibrogenic element in the 
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evolution of IFT. However, the possibility of a secondary 
epiphenomenon is difficult to exclude and, therefore, must 
be considered. 
IFT is generally considered to be a disease process that orig- 
inates within the thyroid gland. The striking degree of tissue 
eosinophilia and eosinophil degranulation that we observed in 
perivascular areas, in the inflamed loose connective tissue, and 
in the interstitial connective tissue between striated muscle fi- 
bers, with virtual sparing of residual thyroid tissue, appears 
difficult to reconcile with this view. In fact, our immunostaining 
results raise the hypothesis that the thyroid gland and adjacent 
neck structures, although central features of multifocal fibrosis, 
are secondarily affected during the progression of a systemic 
fibrogenic process. This view is supported by a recent study 
showing similar marked tissue eosinophilia and degranulation 
in retroperitoneal fibrosis and various other fibrous conditions 
commonly associated with IFI (18). Perhaps, the inflammatory 
and destructive process in IFT is directed against thyroid con- 
nective tissue rather than thyroid epithelial cells and merely 
represents an extension of a cervical fibrosclerotic process into 
the thyroid gland. In fact, the perivascular localization of eosi- 
nophils and extracellular MBP could indicate an allergic process 
that involves blood vessels, supporting similar previous sug- 
gestions (40, 41). Thus, an etiological mechanism such as an 
allergic response against leaking oxidized low density lipopro- 
tein, as proposed recently for idiopathic retroperitoneal fibrosis 
(42, 43), may also apply to IFT. 
Although the primary reason for eosinophil infiltration 
and degranulation in IFT remains unclear, some potential 
mechanisms involved in eosinophil recruitment and access 
to inflamed connective tissue sites can be envisioned. Stim- 
ulated leukocytes, including eosinophils, are capable of bind- 
ing to cytokine-stimulated fibroblasts and endothelial cells, 
and this adhesive interaction is blocked by RGD peptides as 
well as by monoclonal antibodies directed against certain 
leukocyte integrins (19, 44-49). Intercellular adhesion mol- 
ecule-l (ICAM-1; CD54) has been characterized as the re- 
ceptor for the leukocyte integrins LFAl and Mac-l, the pre- 
dominant integrins expressed on human eosinophils (19,44, 
45). In addition, ICAM- has been shown to regulate at least 
in part the adhesion of eosinophils to endothelium both in 
vitro and in vim (19, 50). Further, ICAM- is expressed by 
fibroblasts and endothelial cells, and this expression is 
readily up-regulated by several cytokines (44,49,51). Thus, 
it is possible that ICAM- and other adhesion molecules 
expressed by vascular endothelium, connective tissue cells, 
and thyroid follicular cells after local stimulation by inflam- 
matory mediators contribute to the recruitment of eosi- 
nophils to sites involved by the inflammatory process in IFT. 
In support of this concept, we recently found markedly in- 
creased concentrations of the soluble ICAM- receptor in sera 
derived from patients with active IFT (52). Once recruited to 
a site of inflammatory fibrosclerosis such as the thyroid 
gland, eosinophils may act as antigen-presenting cells capa- 
ble of antigen processing and T cell activation (531, further 
supporting the link between IFT and autoimmune thyroid 
disease (7, 8). 
In conclusion, the presence of eosinophil infiltration and 
extracellular MBP deposition in tissues affected by IFT and 
its absence in other autoimmune and nonautoimmune thy- 
roid conditions, suggests an as yet unrecognized role for 
eosinophils and their products in the pathogenesis of IFT. 
The release of eosinophil-derived products may represent an 
important factor in the evolution of a spectrum of conditions 
characterized by locally aberrant fibrosis, of which IFT may 
be only one manifestation. 
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